Cleander-Yu-2022-Big-Pharma-and-NHS-1Download the article in PDF format *** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines levied against these companies are the result of them abusing their market position as a means to overcharge the … Continue reading Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
Download the article in PDF format *** Introduction *** Confidentiality clauses, non-disclosure agreements (NDAs) or, as they are often called, gagging clauses, are provisions set out in settlement agreements or employment contracts, which serve the purpose to prohibit employees from disclosing particular information to the general public. This article will limit its scope to addressing … Continue reading Gagging Clauses and Whistleblowing in the UK: An Irreconcilable Conflict?
This article has been inspired by the discussion that took place during the international conference "Whistleblowers: Voices of Justice" that was held in London on the 10th of May 2019. The awarding of whistleblowers is a subject that has always presented two polarising views. On one hand, the view is that whistleblowers should be compensated … Continue reading The Competition and Markets Authority’s compensation campaign: Is the UK on the way to adopting an award system for corporate crime reporting?